HRT Financial’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-46,726
Closed -$89K 2222
2025
Q1
$89K Buy
+46,726
New +$89K ﹤0.01% 1936
2024
Q1
Sell
-15,094
Closed -$18K 2112
2023
Q4
$18K Buy
+15,094
New +$18K ﹤0.01% 1877
2023
Q2
Sell
-148,681
Closed -$83K 2196
2023
Q1
$83K Buy
+148,681
New +$83K ﹤0.01% 1902
2022
Q4
Sell
-23,453
Closed -$7K 2227
2022
Q3
$7K Sell
23,453
-1,080,284
-98% -$322K ﹤0.01% 2374
2022
Q2
$389K Buy
1,103,737
+1,078,469
+4,268% +$380K ﹤0.01% 1800
2022
Q1
$18K Sell
25,268
-353,300
-93% -$252K ﹤0.01% 2568
2021
Q4
$855K Buy
+378,568
New +$855K ﹤0.01% 1115
2021
Q3
Sell
-62,446
Closed -$236K 2957
2021
Q2
$236K Sell
62,446
-201,535
-76% -$762K ﹤0.01% 2196
2021
Q1
$893K Buy
+263,981
New +$893K 0.01% 1122
2019
Q4
Sell
-16,367
Closed -$64K 1067
2019
Q3
$64K Buy
+16,367
New +$64K ﹤0.01% 1177